Serum adiponectin and resistin levels in de novo and relapsed acute lymphoblastic leukemia children patients.

Abstract

Low adiponectin and high resistin level at diagnosis suggest their implication in ALL pathogenesis and may serve as potential clinically significant diagnostic markers to detect leukemic relapse.